Abbott announces three-year long-term data evaluating efficacy with HUMIRA® (Adalimumab)
- Details
- Category: Abbott

Abbott reports double digit earnings per share growth in the third quarter
- Details
- Category: Abbott

YERVOY® (ipilimumab) awarded prestigious Prix Galien USA 2012 for best biotechnology product
- Details
- Category: Bristol-Myers Squibb

Roche Group posts strong sales growth in the third quarter
- Details
- Category: Roche

Boehringer Ingelheim congratulates Nobel Prize winner Prof. Brian Kobilka
- Details
- Category: Boehringer Ingelheim

UCB announces third research collaboration with Harvard University
- Details
- Category: UCB

Millions of children in Pakistan to be protected against pneumococcal disease with GSK's Synflorix
- Details
- Category: GlaxoSmithKline

More Pharma News ...
- Sanofi and Bristol-Myers Squibb announce restructuring of alliance agreement
- ELIQUIS® (apixaban) demonstrates consistent reductions in stroke and systemic embolism, major bleeding and mortality
- Bayer's Stivarga® (regorafenib) tablets approved by FDA for treatment of metastatic colorectal cancer
- Abbott's HUMIRA® (adalimumab) receives FDA approval for the treatment of ulcerative colitis
- Bayer joins global initiative for better access to safe and effective contraception
- Abbott announces international launch of the Absorb(TM)
- Novo Nordisk invests further in China